Advancing ClinicalTrials: Tigermed's Britney Winterberger
Release Date: 03/23/2024
Revolutionizing Neuropsychiatry: Dr. Sam Clark Therapeutics and Innovation
Life Science Success
In this episode of Life Science Success, host Don interviews Dr. Sam Clark, founder and CEO of Terran Biosciences. They talk about Dr. Clark's innovative approach to creating new neuropsychiatric therapeutics and how his personal experiences with mental illness inspired him to enter the biotech industry. The episode also explores various breakthroughs at Terran, including their innovative work with prodrugs, anti-psychotics, and psychedelics, along with their unique, efficient team structure modeled after Silicon Valley tech companies. Additionally, they delve into the inspiration,...
info_outline
Life Science Success with Vance Lyon: From Chemistry to Pharma Innovation
Life Science Success
In this episode of Life Science Success, host Don interviews Vance Lyon, an accomplished chemist with a four-decade career in the life sciences industry. Vance discusses his educational background, career journey, and key experiences. The conversation also delves into the vital role of Davos Pharma in providing comprehensive services for biotech companies, including API production, formulation, and IND filings. Vance shares insights on leadership, his inspirations, and concerns, while reflecting on his contributions to significant pharmaceutical projects. Join us for an engaging...
info_outline
Dr. William Chou on Gene Therapy for Neurodegenerative Diseases
Life Science Success
In this episode of the Life Science Success Podcast, host Don Davis, PhD, MBA, interviews Dr. William Chou of Passage Bio. Dr. Chou discusses his transition from a practicing physician to a leader in biotechnology, reflects on the profound patient relationships he misses, and shares insights into Passage Bio's work on gene therapy for neurodegenerative diseases like Frontotemporal Dementia (FTD). They delve into the progress of their Phase 1/2 clinical study, the urgency of developing treatments for genetic mutations, and the potential impact on patients and their families. Learn about...
info_outline
Revolutionizing Gene Therapy with Igor Fisch CEO of NewBiologix
Life Science Success
In this episode of the Life Science Success Podcast, Don Davis PhD, MBA interviews Igor Fisch, founder of NewBiologix. Igor shares his journey from academia to entrepreneurship, highlighting his success with Selexis, a company he sold in 2017 that specialized in monoclonal antibodies. He discusses the challenges of gene therapy, specifically the high costs, and NewBiologix's innovative approach to making gene therapy more affordable. Igor also provides insights into the industry's future, emphasizing the significance of stable production platforms for viral particles. Introduction and Welcome...
info_outline
Exploring Neuroprotective Drugs with Dean Petkanas CEO of Kannalife Sciences
Life Science Success
In this episode of the Life Science Success Podcast, Dean Petkanas, co-founder of Kannalife Sciences, is interviewed at the Bio International Convention in San Diego. Dean shares his journey from investment banking in the 80s to founding Kannalife Sciences in 2009. He discusses the company's focus on developing cannabinoid-based drugs, specifically targeting chemotherapy-induced peripheral neuropathy. The conversation covers the challenges and opportunities in cannabinoid drug development, the importance of targeting specific types of pain, and the current state and future prospects of...
info_outline
Revolutionizing Lung Disease Treatment with Evoke Nano's CEO Sean Rothwell
Life Science Success
In this episode of the Life Science Success Podcast, host Don interviews Sean Rothwell, CEO of Evoke Nano, about the company's groundbreaking work in developing EBQ218, a revolutionary nanoparticle-based pulmonary therapeutic. They discuss the efficacy of EBQ218 in treating cystic fibrosis and its potential as a broad-spectrum antibiotic against drug-resistant superbugs. Sean shares insights into the company's journey, their upcoming clinical trials, and the broader impact of their work on patient outcomes in the healthcare landscape. Tune in to learn how Evoke Bio is poised to make a...
info_outline
Virtual Human Twins: Revolutionizing Drug and Device Testing | Elem Biotech Pt2
Life Science Success
This is the second part of the interview where, with Maruiano, we will discuss more of the technology and development for Elem Biotech. In this episode of the Life Science Success Podcast, Don Davis discusses the BIO conference and the future of biomedical research with Mauriano Vázquez. They delve into the significance of networking events, the evolution of computing capabilities, advanced simulation codes, and the potential applications of AI and quantum computing in life sciences. Mauriano shares his unique journey from Argentina to becoming a physicist specializing in...
info_outline
Virtual Human Twins: Revolutionizing Drug and Device Testing | Elem Biotech Pt1
Life Science Success
There are two parts of this interview, in the first session, I dive into Elem and what the company is doing with Christopher Morton. In this exciting episode of Life Science Discussed Podcast, host Don Davis welcomes Christopher Morton, CEO of Elem Biotech, to talk about the groundbreaking work of virtual human twins in drug and medical device testing. Morton, an aeronautical engineer turned biotech innovator, discusses Elem's platform that allows pharmaceutical companies, medtechs, and CROs to test new therapeutics using virtual human models instead of animal models. They...
info_outline
Breaking Barriers in Pain Management and ADHD Treatment with Tris Pharma James Hackworth
Life Science Success
In this episode of the Lifescience Success Podcast, host Don Davis interviews James Hackworth, who shares insights about his background in physics and his journey into the life science industry. James discusses his experiences from McKinsey up to his current role at Tris Pharma, focusing on their innovative drug development and formulation technologies. He dives into the company's advancements in ADHD medications and an exciting new pain management drugs. Additionally, the conversation highlights the importance of partnerships, technology in drug development, and future industry trends....
info_outline
Innovating Biotech: Enzine's Continuous Manufacturing Platform with Himanshu Gadgil
Life Science Success
In this episode of the Life Science Success Podcast, Don interviews Himanshu Gadgil from Enzine during Bio International. Himanshu explains Enzine’s dual focus on developing biosimilars and their role as a CDMO with a game-changing platform, Enzine X. They discuss how Enzine's continuous manufacturing technology significantly cuts costs and speeds up market access for clients. Himanshu also talks about Enzine’s global presence, clientele, and their future plans for expansion in the U.S. and India. Tune in to learn about the innovative approaches Enzine is bringing to the biotech...
info_outlineIn this episode of Life Science Success, we're thrilled to welcome Britney Winterberger, the Senior Director of North America Project Management and Clinical Operations at Tigermed. Britney brings a wealth of experience in clinical trials across various therapeutic areas and a deep personal commitment to advancing patient treatments, particularly in the fight against cancer.
- Britney Winterberger is the Senior Director of North America Project Management and Clinical Operations at Tigermed, with a rich career history in life sciences, inspired by a personal loss to leukemia. She initially aspired to be a pediatric oncologist but shifted towards clinical research to contribute to cancer treatment advancements.
- Winterberger, who was born and raised in Cincinnati, Ohio, has a Marquette University undergraduate degree in biological sciences as well as study abroad experiences. She is also a family person, emphasizing the importance of travel, outdoor activities, and being sports enthusiasts with her husband and two children.
- Her journey into the field of life sciences was somewhat unintentional, transitioning from a goal in pediatric oncology to clinical research due to the emotional challenges of the former. She transitioned because of a special opportunity through a family connection, which led her to a career in clinical research organizations (CROs).
- Throughout her career, pivotal moments included receiving a 'B' on a performance review, which was a significant learning experience for her, highlighting the importance of adaptability, innovation, and the need to work in a more agile and innovative environment. Joining Tigermed represented a culminating point where she found a space to innovate and drive meaningful change in the clinical research landscape.
- Winterberger discusses the evolution of clinical trials, emphasizing the shift towards patient-centric approaches, the integration of digital health technologies, and the push for decentralized clinical trials to improve patient access and compliance. She also highlights Tigermed's role in advancing clinical research through innovative trial designs and efficient patient recruitment strategies, underlining her commitment to making a difference in cancer treatment and patient care.